CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Trial of AMG 479 or Placebo in Combination With Gemcitabine as First Line Therapy for Metastatic Adenocarcinoma of the Pancreas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01231347
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:22.132024+00:00
Published At: 2024-07-16T00:00:00+00:00
Record Updated At: 2024-07-16
Results Posted At: 2024-07-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Adenocarcinoma of the Pancreas", "Advanced Solid Tumors", "Cancer", "Cancer of Pancreas", "Cancer of the Pancreas", "Metastases", "Metastatic Cancer", "Metastatic Pancreatic Cancer", "Pancreas Cancer", "Pancreatic Cancer", "Bone Metastases", "Endocrine Cancer", "Oncology", "Oncology Patients", "Solid Tumors", "Advanced Malignancy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-07-16"
protocolSection.identificationModule.nctId: "NCT01231347"
protocolSection.identificationModule.officialTitle: "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Trial of AMG 479 or Placebo in Combination With Gemcitabine as First Line Therapy for Metastatic Adenocarcinoma of the Pancreas"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2024-07-16"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.